GeoVax Labs, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.5M | $4.0M | $0 | $81,526 | $385,501 |
| Operating income | -$21.6M | -$25.1M | -$26.7M | -$14.0M | -$18.7M |
| Operating expenses | $24.1M | $29.1M | $26.7M | $14.1M | $19.1M |
| Cash from operations | -$21.5M | -$24.7M | -$25.2M | -$19.0M | -$11.2M |
| Capital expenditure | $27,612 | $20,653 | $48,946 | $134,258 | $47,718 |
| Free cash flow | -$21.5M | -$24.7M | -$25.2M | -$19.2M | -$11.2M |
| Share repurchases | — | — | — | — | $1,000 |
| Total assets | $6.3M | $8.2M | $9.3M | $31.3M | $11.8M |
| Total liabilities | $2.5M | $3.1M | — | $4.7M | $7.4M |
Shares outstanding 3.5M · Free float 100.0%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.